Juliane S. Falcão

Juliane S. Falcão

Auto-generated profile, based on publicly available information

Juliane S. Falcão

Laboratório de Química Bioorgânica (LQB), Instituto de Pesquisa de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2025 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
JFJuliane S. Falcão
Juliane S. Falcão
MSMarcos V. O. da Silva
Marcos V. O. da Silva
EREdivaldo S. Dos Santos Rodrigues
Edivaldo S. Dos Santos Rodrigues
Osvaldo Andrade Santos-FilhoOsvaldo Andrade Santos-Filho
Osvaldo Andrade Santos-Filho
PCPaulo Costa
Paulo Costa
Guilherme S. CaleffiGuilherme S. Caleffi
Guilherme S. Caleffi
A mild and highly efficient one-pot asymmetric transfer hydrogenation (ATH) of challenging, electron-rich 3-arylidenechroman-4-ones is reported.

1 January 2026 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
JFJuliane S. Falcão
Juliane S. Falcão
JNJosé B. Vieira Neto
José B. Vieira Neto
Cláudia PessoaCláudia Pessoa
Cláudia Pessoa
PCPaulo Costa
Paulo Costa
Guilherme S. CaleffiGuilherme S. Caleffi
Guilherme S. Caleffi
(+)-2,3,9-Trimethoxypterocarpan [(+)-PTC] is a naturally occurring isoflavonoid that exhibits potent antitumor activity, putatively acting through the inhibition of kinesin-5 (Eg5), a mechanism distinct from classic tubulin-targeting agents. However, its preclinical development has been severely hampered by supply limitations, as previous synthetic routes relied on inefficient racemic strategies requiring laborious chiral resolution. Herein, we report a concise, biomimetic, and enantioselective total synthesis of (+)-PTC that overcomes these challenges. The route features a robust ligand-free Suzuki cross-coupling in PEG-400 and utilizes a ruthenium-catalyzed asymmetric transfer hydrogenation coupled with dynamic kinetic resolution (ATH-DKR) as the key stereodefining step. Optimized conditions enabled the scale-up of the key reduction with a low catalyst loading (2 mol%), delivering the pterocarpan core with high optical purity (98% ee) and excellent diastereocontrol. The synthesis was completed in just six steps with 64% overall yield, securing a sustainable supply of the bioactive enantiomer for advanced biological validation and providing divergent access to optically pure isoflavanone analogues.